AG
AGN

AlphaSimPlex Group’s Allergan plc AGN Stock Holding History

AlphaSimPlex Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,651
Closed -$1.71M – 285
2020
Q1 		$1.71M Sell
9,651
-3,525
-27% -$664K 2.58% 7
2019
Q4 		$2.52M Sell
13,176
-3,959
-23% -$714K 0.95% 7
2019
Q3 		$2.88M Sell
17,135
-3,234
-16% -$527K 1.1% 3
2019
Q2 		$3.41M Buy
+20,369
New +$2.82M 1.06% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AlphaSimPlex Group's AGN Position: Q2 2020 in Review

AlphaSimPlex Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,651 shares — an estimated $1.71M sold.

AlphaSimPlex Group first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $3.41M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AlphaSimPlex Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AlphaSimPlex Group sold 9,651 Allergan plc shares in Q2 2020, an estimated $1.71M.
  • AlphaSimPlex Group first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • AlphaSimPlex Group's Allergan plc position peaked at $3.41M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AlphaSimPlex Group's 13F filing for Q2 2020, filed 14 Aug 2020.